Flow Cytometry was reported in scientific literature. This antibody shows approximately some degree (40%) cross-reactivity with rPDGF-AB and no cross-reactivity with recombinant PDGF-AA. Proteinase K (20ug/ml in PBS) is recommended for antigen retrieval. This antibody is CyTOF ready.
Read 1 Review rated 4 using NB110-60980 in the following applications:
Platelet Derived Growth Factor (PDGF) is the major serum mitogen for cells of mesenchymal origin in humans. The biologically active protein is a dimmer composed of two related polypeptides designated A and B. The PDGF protein has been implicated both directly as well as indirectly in several pathological states including neoplasia, arthritis, arteriosclerosis and bone marrow sclerosis.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
IHC (P) on equine endometrium using the antibody at 1:200 dilution. Protein is expressed primarily in the luminal epithelium and to a lesser extent in glandular epithelium. No staining on neg. control (omission of the prim AB and replacement with mouse normal serum). Heat-induced antigen retrieval with EDTA based solution for 10 min.
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.